Skip to main content
SpringerLink
Log in

Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Earlier studies have shown the effect of laser treatment on epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT). At the present time, only very few prospective trials have been performed, and many studies are based on patients’ subjective assessment of the severity of epistaxis. This prospective study measures the objective effect of laser treatment in HHT patients with mild to moderate epistaxis. We introduce an objective measure to assess the severity of epistaxis: the bleeding time (BT). Before and after treatment, the quality of life, as measured by the patient, was assessed and compared to normative data. In 30 patients, we measured the BT before laser treatment 1.5 and 6.5 months after treatment. The Short form 36 (SF-36), a validated health questionnaire, was completed before and 6.5 months after treatment. Compared to preoperative value, BT was significantly reduced 1.5 and 6.5 months after laser treatment (p < 0.05) in both cases. No significant difference in quality of life, before and after treatment, was found. The quality of life of the HHT patients was reduced in five out of eight dimensions when compared with the Danish background population. Laser treatment reduces epistaxis in HHT patients with mild to moderate epistaxis for at least 6 months; this group of patients have reduced quality of life compared to the background population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66–67

    Article  PubMed  CAS  Google Scholar 

  2. Kjeldsen AD, Vase P, Green A (2000) Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients. Ugeskr Laeger 162(25):3597–3601

    PubMed  CAS  Google Scholar 

  3. Lennox PA, Harries M, Lund VJ, Howard DJ (1997) A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 111(1):34–37

    Article  PubMed  CAS  Google Scholar 

  4. Kluger PB, Shapshay SM, Hybels RL, Bohigian RK (1987) Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report. Laryngoscope 97(12):1397–1401

    Article  PubMed  CAS  Google Scholar 

  5. Illum P, Bjerring P (1988) Hereditary hemorrhagic telangiectasia treated by laser surgery. Rhinology 26(1):19–24

    PubMed  CAS  Google Scholar 

  6. Lennox PA, Hitchings AE, Lund VJ, Howard DJ (2005) The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19(1):71–74

    PubMed  Google Scholar 

  7. Al-Deen S, Bachmann-Harildstad G (2008) A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Rhinology 46(4):281–284

    Google Scholar 

  8. Pagella F, Semino L, Olivieri C, Corno S, Dore R, Draghi F et al (2006) Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia. Am J Rhinol 20(4):421–425

    Article  PubMed  Google Scholar 

  9. Kuhnel TS, Wagner BH, Schurr CP, Strutz J (2005) Clinical strategy in hereditary hemorrhagic telangiectasia. Am J Rhinol 19(5):508–513

    PubMed  Google Scholar 

  10. Karapantzos I, Tsimpiris N, Goulis DG, Van HH, Van CP, Danielides V (2005) Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262(10):830–833

    Article  PubMed  Google Scholar 

  11. Geisthoff UW, Heckmann K, D’Amelio R, Grunewald S, Knobber D, Falkai P et al (2007) Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 136(5):726–733

    Article  PubMed  Google Scholar 

  12. Bjoerner JB, Damsgaard MT, Watt T et al (1997) Danish manual to SF-36. LIF, Copenhagen (In danish)

    Google Scholar 

  13. Geisthoff UW, Fiorella ML, Fiorella R (2006) Treatment of recurrent epistaxis in HHT. Curr Pharm Des 12(10):1237–1242

    Article  PubMed  CAS  Google Scholar 

  14. Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120(4):838–843

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Oto Rhino Laryngology, OUH Svendborg Sygehus, Valdemarsgade 53, 5700, Svendborg, Denmark

    Gita Jørgensen

  2. Department of Oto Rhino Laryngology, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark

    Bibi Lange, Jens Højberg Wanscher & Anette Drøhse Kjeldsen

Authors
  1. Gita Jørgensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bibi Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jens Højberg Wanscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anette Drøhse Kjeldsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anette Drøhse Kjeldsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jørgensen, G., Lange, B., Wanscher, J.H. et al. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia. Eur Arch Otorhinolaryngol 268, 1765–1770 (2011). https://doi.org/10.1007/s00405-011-1677-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-011-1677-9

Keywords

Search

Navigation